Table 3 |
||
|
Agonist peptides and reverse peptides of PARs used in the study |
||
|
PAR |
Agonist peptides |
Reverse peptides |
|
|
||
|
PAR-1 |
SFLLR-NH2 |
RLLFS-NH2 |
|
PAR-2 |
SLIGKV-NH2 |
VKGILS-NH2 |
|
PAR-4 |
GYPGQV-NH2 |
VQGPYG-NH2 |
|
|
||
|
Qiao et al. BMC Cell Biology 2009 10:62 doi:10.1186/1471-2121-10-62 |
||
